Correlation Between Effector Therapeutics and Greenwich Lifesciences
Can any of the company-specific risk be diversified away by investing in both Effector Therapeutics and Greenwich Lifesciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Effector Therapeutics and Greenwich Lifesciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Effector Therapeutics and Greenwich Lifesciences, you can compare the effects of market volatilities on Effector Therapeutics and Greenwich Lifesciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Effector Therapeutics with a short position of Greenwich Lifesciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Effector Therapeutics and Greenwich Lifesciences.
Diversification Opportunities for Effector Therapeutics and Greenwich Lifesciences
0.33 | Correlation Coefficient |
Weak diversification
The 3 months correlation between Effector and Greenwich is 0.33. Overlapping area represents the amount of risk that can be diversified away by holding Effector Therapeutics and Greenwich Lifesciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Greenwich Lifesciences and Effector Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Effector Therapeutics are associated (or correlated) with Greenwich Lifesciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Greenwich Lifesciences has no effect on the direction of Effector Therapeutics i.e., Effector Therapeutics and Greenwich Lifesciences go up and down completely randomly.
Pair Corralation between Effector Therapeutics and Greenwich Lifesciences
If you would invest 1,415 in Greenwich Lifesciences on August 28, 2024 and sell it today you would lose (21.00) from holding Greenwich Lifesciences or give up 1.48% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 2.38% |
| Values | Daily Returns |
Effector Therapeutics vs. Greenwich Lifesciences
Performance |
| Timeline |
| Effector Therapeutics |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
| Greenwich Lifesciences |
Effector Therapeutics and Greenwich Lifesciences Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Effector Therapeutics and Greenwich Lifesciences
The main advantage of trading using opposite Effector Therapeutics and Greenwich Lifesciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Effector Therapeutics position performs unexpectedly, Greenwich Lifesciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Greenwich Lifesciences will offset losses from the drop in Greenwich Lifesciences' long position.| Effector Therapeutics vs. Indaptus Therapeutics | Effector Therapeutics vs. Jasper Therapeutics | Effector Therapeutics vs. RenovoRx | Effector Therapeutics vs. Ensysce Biosciences |
| Greenwich Lifesciences vs. Reviva Pharmaceuticals Holdings | Greenwich Lifesciences vs. Eyenovia | Greenwich Lifesciences vs. Immutep Ltd ADR | Greenwich Lifesciences vs. Anavex Life Sciences |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Complementary Tools
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities |